UNSPSC 51182052: Methandriol diacetate

This classification denotes an anabolic steroid with the molecular formula C24H36O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z142SX9228, chemically known as androst-5-ene-3,17-diol, 17-methyl-, 3,17-diacetate, (3.beta.,17.beta.)-, but more generally known as methandriol diacetate, which bears US NIH Compound Identifier 102203. European Medicines Agency schedules methandriol diacetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08835MIG.

Most nations, for tariff purposes, schedule methandriol diacetate under HS 29372900. SMILES: CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@]4(C)OC(=O)C)C)C.

UNSPSC 51182052 Methandriol diacetate is a Commodity code covering a synthetic anabolic steroid pharmaceutical product. State and local procurement activity under this code is minimal to absent; the recent-opportunities block contains no posted solicitations for methandriol diacetate from state agencies, counties, municipalities, school districts, transit authorities, or other state and local public bodies. The code represents a narrow pharmaceutical product class unlikely to appear in routine state and local procurement cycles, as methandriol diacetate is a controlled substance with limited legitimate medical use and is subject to federal scheduling and distribution restrictions that sharply constrain public-sector purchasing.

Without documented recent opportunities in the state and local space, no issuing-body mix, geographic concentration, or representative solicitations can be characterized. Business development professionals should monitor this code only if their firm holds specialized pharmaceutical distribution licenses and contracts with state health departments or corrections agencies for legitimate medical uses; for most vendors, the code presents no current pursuit opportunity in state and local procurement.